# Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

> **NCT00047060** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 5 (actual)

## Conditions studied

- Mycosis Fungoides
- Sezary Syndrome

## Interventions

- **OTHER:** A matched peripheral donor stem cells
- **DRUG:** cyclosporine
- **DRUG:** fludarabine
- **DRUG:** Campath

## Key facts

- **NCT ID:** NCT00047060
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07-30
- **Primary completion:** 2019-01-24
- **Final completion:** 2019-01-24
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047060, "Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00047060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*